10x Genomics, Inc. TXG Total Operating Expenses
Total Operating Expenses at other companies
Other financials
Where this comes from
Reported directly by 10x Genomics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The official record: 10x Genomics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about 10x Genomics, Inc.'s total operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is 10x Genomics, Inc.'s total operating expenses?
- 10x Genomics, Inc. (TXG) reported total operating expenses of $123.22M in Q1 2026.
- How has 10x Genomics, Inc.'s total operating expenses changed year-over-year?
- 10x Genomics, Inc.'s total operating expenses decreased by 14.9% year-over-year, from $144.77M to $123.22M.
- What is the long-term trend for 10x Genomics, Inc.'s total operating expenses?
- Over 4 years (2021 to 2025), 10x Genomics, Inc.'s total operating expenses has grown at a 1.9% compound annual growth rate (CAGR), from $468.65M to $504.87M.
- What does total operating expenses mean?
- The sum of all operating costs including COGS, SG&A, R&D, D&A, and other operating charges. Revenue minus total operating expenses equals operating income.